These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15322541)
1. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. LeibundGut-Landmann S; Waldburger JM; Reis e Sousa C; Acha-Orbea H; Reith W Nat Immunol; 2004 Sep; 5(9):899-908. PubMed ID: 15322541 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831 [TBL] [Abstract][Full Text] [Related]
3. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420 [TBL] [Abstract][Full Text] [Related]
4. [Specific promoter activity of CIITA-pI in dendritic cells]. Zhang Y; Shen Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):55-7. PubMed ID: 15182622 [TBL] [Abstract][Full Text] [Related]
5. Revisiting the specificity of the MHC class II transactivator CIITA in vivo. Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565 [TBL] [Abstract][Full Text] [Related]
6. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter. Choi YE; Yu HN; Yoon CH; Bae YS Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634 [TBL] [Abstract][Full Text] [Related]
7. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells. Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519 [TBL] [Abstract][Full Text] [Related]
9. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL). Cycon KA; Rimsza LM; Murphy SP Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173 [TBL] [Abstract][Full Text] [Related]
10. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421 [TBL] [Abstract][Full Text] [Related]
11. Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs. Märten A; Ziske C; Schöttker B; Weineck S; Renoth S; Buttgereit P; Schakowski F; König S; von Rücker A; Allera A; Schroers R; Sauerbruch T; Wittig B; Schmidt-Wolf IG Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992 [TBL] [Abstract][Full Text] [Related]
12. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA). Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870 [TBL] [Abstract][Full Text] [Related]
13. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival. Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431 [TBL] [Abstract][Full Text] [Related]
14. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta. Harnesk K; Swanberg M; Diez M; Olsson T; Piehl F; Lidman O J Neuroimmunol; 2009 Jul; 212(1-2):44-52. PubMed ID: 19481818 [TBL] [Abstract][Full Text] [Related]
15. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells. Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139 [TBL] [Abstract][Full Text] [Related]
17. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052 [TBL] [Abstract][Full Text] [Related]
18. T cell expression of CIITA represses Th1 immunity. Park WS; Bae Y; Chung DH; Choi YL; Kim BK; Sung YC; Choi EY; Park SH; Jung KC Int Immunol; 2004 Oct; 16(10):1355-64. PubMed ID: 15351782 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells. Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207 [TBL] [Abstract][Full Text] [Related]
20. Prolonged MHC class II expression and CIITA transcription in human keratinocytes. Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]